France has expanded its vaccination programme against meningococcal disease from 1 January in response to a rise in cases, particularly among children and teenagers who are more vulnerable to severe forms of meningitis.
The move aims to combat infections caused by meningococcal bacteria, which can lead to bacterial meningitis – a highly contagious and potentially deadly illness.
